Intraoperative Echocardiography for Heart Disease
What You Need to Know Before You Apply
What is the purpose of this trial?
This goal of this study is to better understand when and where intraoperative transesophageal echocardiography (TEE) should (or should not) be used during coronary artery bypass graft (CABG) surgeries.
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. Please consult with the trial coordinators for guidance.
Is intraoperative echocardiography safe for use in humans?
Intraoperative echocardiography is widely used in cardiac surgeries and is considered a valuable tool for monitoring and decision-making during operations. It has been reported to have a positive impact on patient outcomes, and no specific safety concerns have been highlighted in the available research.12345
How is intraoperative echocardiography different from other treatments for heart disease?
Intraoperative echocardiography is unique because it allows surgeons to see the heart in real-time during surgery, helping them to better understand the heart's structure and function, and to immediately evaluate the success of the surgery. This real-time imaging is not possible with other treatments, making it a valuable tool for improving surgical outcomes.23467
What data supports the effectiveness of the treatment Intraoperative Echocardiography for Heart Disease?
Intraoperative echocardiography is shown to be effective in improving surgical outcomes by allowing surgeons to see the heart in action, assess heart function, and make immediate decisions during surgery. It is particularly useful in high-risk heart surgeries, such as coronary artery bypass grafting, and helps in diagnosing and managing complications during procedures.348910
Who Is on the Research Team?
Emily MacKay, DO, MS
Principal Investigator
University of Pennsylvania, Penn Medicine
Are You a Good Fit for This Trial?
This trial is for adults over 18 who are scheduled for low-risk isolated CABG surgery, have a good heart pump function (ejection fraction ≥50%), and recent heart tests. It's not for those with moderate or severe valve disease, planned aortic interventions, critical coronary disease, end-stage kidney disease on dialysis, certain esophageal conditions, or severe pulmonary hypertension.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo coronary artery bypass graft (CABG) surgery with either default or as-needed intraoperative transesophageal echocardiography (TEE)
Follow-up
Participants are monitored for safety and effectiveness after surgery, including assessment of gastroesophageal and end-organ dysfunction, and incidence of cardiovascular re-intervention or mortality
What Are the Treatments Tested in This Trial?
Interventions
- Intraoperative Echocardiography
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Pennsylvania
Lead Sponsor
National Institutes of Health (NIH)
Collaborator